1. Home
  2. CTKB

CTKB

Cytek Biosciences Inc.

Logo Cytek Biosciences Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-24-2024 2:13pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Founded: 1990 Country:
N/A
Employees: N/A City: FREMONT
Market Cap: 774.5M IPO Year: 2021
Target Price: $9.00 AVG Volume (30 days): 699.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.09 EPS Growth: N/A
52 Week Low/High: $3.80 - $12.31 Next Earning Date: 01-01-0001
Revenue: $193,015,000 Revenue Growth: 17.67%
Revenue Growth (this year): 9.85% Revenue Growth (next year): 18.85%

Share on Social Networks:

Stock Insider Trading Activity of Cytek Biosciences Inc. (CTKB)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Yan Ming CTKB CHIEF TECHNOLOGY OFFICER Apr 9 '24 Sell $7.00 1,500 $10,500.00 6,008,902 SEC Form 4
Yan Ming CTKB CHIEF TECHNOLOGY OFFICER Apr 9 '24 Sell $7.01 400 $2,804.00 6,008,502 SEC Form 4
Jeanmonod Patrik CTKB Chief Financial Officer Dec 26 '23 Sell $9.50 3,000 $28,500.00 93,400 SEC Form 4
Yan Ming CTKB Chief Technology Officer Dec 19 '23 Sell $9.43 20,000 $188,600.00 6,042,103 SEC Form 4
Jeanmonod Patrik CTKB Chief Financial Officer Nov 24 '23 Sell $6.94 3,000 $20,820.00 96,400 SEC Form 4
Yan Ming CTKB Chief Technology Officer Nov 18 '23 Sell $6.03 20,000 $120,600.00 7,762,103 SEC Form 4
Jiang Wenbin CTKB President and CEO Nov 7 '23 Sell $4.34 20,000 $86,800.00 5,275,796 SEC Form 4
Jeanmonod Patrik CTKB Chief Financial Officer Oct 24 '23 Sell $4.68 3,000 $14,040.00 96,084 SEC Form 4